APA (7th ed.) Citation

Matsuzawa, F., Kamachi, H., Mizukami, T., Einama, T., Kawamata, F., Fujii, Y., . . . Taketomi, A. (2021). Mesothelin blockage by Amatuximab suppresses cell invasiveness, enhances gemcitabine sensitivity and regulates cancer cell stemness in mesothelin-positive pancreatic cancer cells. BMC Cancer, 21(1), 1. https://doi.org/10.1186/s12885-020-07722-3

Chicago Style (17th ed.) Citation

Matsuzawa, Fumihiko, et al. "Mesothelin Blockage by Amatuximab Suppresses Cell Invasiveness, Enhances Gemcitabine Sensitivity and Regulates Cancer Cell Stemness in Mesothelin-positive Pancreatic Cancer Cells." BMC Cancer 21, no. 1 (2021): 1. https://doi.org/10.1186/s12885-020-07722-3.

MLA (9th ed.) Citation

Matsuzawa, Fumihiko, et al. "Mesothelin Blockage by Amatuximab Suppresses Cell Invasiveness, Enhances Gemcitabine Sensitivity and Regulates Cancer Cell Stemness in Mesothelin-positive Pancreatic Cancer Cells." BMC Cancer, vol. 21, no. 1, 2021, p. 1, https://doi.org/10.1186/s12885-020-07722-3.